Have we entered a period where people are screening too much for disease? The Wall Street Journal put the question to The Experts, an exclusive group of industry and thought leaders who engage in in-depth online discussions of topics. Jeffrey S. Flier, dean of the faculty of medicine at Harvard University, offered his perspective.